Establishment and characteristics of two syngeneic human osteosarcoma cell lines from primary tumor and skip metastases

Acta Pharmacologica Sinica

Volumn 29, Issue 3, 2008, Pages 325-332

  Zou, Chang Ye ^a   Wang, Jin ^a   Shen, Jing Nan ^a   Huang, Gang ^a   Jin, Song ^a   Yin, Jun Qiang ^a   Guo, Qian Chen ^a   Li, Hao Miao ^a   Luo, Lan ^a   Zhang, Meng ^a   Zhang, Long Juan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Osteosarcoma; Skip metastasis; Zos; Zos M

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CADHERIN; CISPLATIN; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE;

ADULT; ANEUPLOIDY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CARCINOGENICITY; CASE REPORT; CELL LINEAGE; CELL PROLIFERATION; CELL STRUCTURE; CHROMOSOME ANALYSIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KARYOTYPE; LUNG METASTASIS; MALE; MICROSCOPY; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIMARY TUMOR; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 39849102635     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00756.x     Document Type: Article

References (30)

1. 1 Link MP, Eilber F. Pediatric oncology: osteosarcoma. In: Pizzo P A, Poplack DG. editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott ; 1989. p 689–711.
2. 2 Bielack SS, Kempf‐Bielack B, Delling G, Exner GU, Flege S, Helmke K, et al. Prognostic factors in high‐grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002 ; 20: 776–90.
3. 3 Bruland OS, Pihl A. On the current management of osteosarcoma: a critical evaluation and a proposal for a modifed treatment strategy. Eur J Cancer 1997 ; 33: 1725–31.
4. 4 Enneking WF, Kagan A. The implications of “skip” metastases in osteosarcoma. Clin Orthop 1975 ; 111: 33–41.
5. 5 Malawer MM, Dunham WK. Skip metastases in osteosarcoma: Recent experience. J Surg Oncol 1983 ; 22: 236–45.
6. 6 Sajadi KR, Heck RK, Neel MD, Rao BN, Daw N, Rodriguez‐Galindo C, et al. The incidence and prognosis of osteosarcoma skip metastases. Clin Orthop Relat Res 2004 ; 426: 92–6.
7. 7 Kager L, Zoubek A, Kastner U, Kempf‐Bielack B, Potratz J, Kotz R, et al. Cooperative Osteosarcoma Study Group. Skip metastases in osteosarcoma: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol 2006 ; 24: 1535–41.
8. 8 Berlin O, Samid D, Donthineni‐Rao R, Akeson W, Amiel D, Woods VL Jr. Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymicmice. Cancer Res 1993 ; 53: 4890–5.
9. 9 Fournierf, B. Price, P.A. Characterization of a new human osteosarcoma cell line OHS‐4 J Cell Biol 1991 ; 114: 577–83.
10. 10 Narita M, Nomura J, Nakase M, Inui M, Murata T, Hamaguchi Y, et al. Characterization of the human mandibular osteoblastic osteosarcoma cell line HOSM‐2 after long‐term culture. Oral Oncol 2004 ; 40: 742–50.
11. 11 Kimura K, Nakano T, Park YB, Tani M, Tsuda H, Beppu Y, et al. Establishment of human osteosarcoma cell lines with high metastatic potential to lungs and their utilities for therapeutic studies on metastatic osteosarcoma. Clin Exp Metastasis 2002 ; 19: 477–85.
12. 12 Asai T, Ueda T, Itoh K, Yoshioka K, Aoki Y, Mori S, et al. Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int J Cancer 1998 ; 76: 418–22.
13. 13 Kashima T, Nakamura K, Kawaguchi J, Takanashi M, Ishida T, Aburatani H, et al. Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo. Int J Cancer 2003 ; 104: 147–54.
14. 14 Iwaya K, Ogawa H, Kuroda M, Izumi M, Ishida T, Mukai K. Cytoplasmic and/or nuclear staining of beta‐catenin is associated with lung metastasis. Clin Exp Metastasis 2003 ; 20: 525–9.
15. 15 Fukaya Y, Ishiguro N, Senga T, Ichigotani Y, Sohara Y, Tsutsui M, et al. A role for PI3K‐Akt signaling in pulmonary metastatic nodule formation of the osteosarcoma cell line, LM8. Oncol Rep 2005 ; 14: 847–52.
16. 16 Khanna C, Khan J, Nguyen P, Prehn J, Caylor J, Yeung C, et al. Metastasis‐associated differences in gene expression in a murine model of osteosarcoma. Cancer Res 2001 ; 61: 3750–9.
17. 17 Sandberga AA, Bridgeb JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. Cancer Genet Cytogenet 2003 ; 145: 1–30.
18. 18 Goorin AM, Shuster JJ, Baker A, Horowitz ME, Meyer WH, Link MP. Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multiinstitutional osteosarcoma study. J Clin Oncol 1991 ; 9: 600–5.
19. 19 Bacci G, Ferrari S, Longhi A, Perin S, Forni C, Fabbri N, et al. Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy. Eur J Cancer 2001 ; 37: 32–8.
20. 20 Kempf‐Bielack B, Bielack SS, Jurgens H, Branscheid D, Berdel WE, Exner GU, et al. Osteosarcoma relapse after combined modality therapy: An analysis of unselected patients in the cooperative osteosarcoma study group (COSS). J Clin Oncol 2005 ; 23: 559–68.
21. 21 Giuliano A, Feig S, Eilber FR. Changing metastatic pattern in osteosarcoma. Cancer 1984 ; 54: 2160–4.
22. 22 Ferrari S, Briccoli A, Mercuri M, Bertoni F, Picci P, Tienghi A, et al. Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long‐term survival. J Clin Oncol 2003 ; 21: 710–5.
23. 23 Greene FL, Page DL, Fleming ID. AJCC cancer staging manual, 6th ed. New York: Springer‐Verlag ; 2002.
24. 24 Wuisman P, Enneking WF. Prognosis for patients who have osteosarcoma with skip metastasis. J Bone Joint Surg 1990 ; 72A: 60–8.
25. 25 Kashima T, Kawaguchi J, Takeshita S, Kuroda M, Takanashi M, Horiuchi H, et al. Anomalous cadherin expression in osteosarcoma possible relationships to metastasis and morphogenesis. Am J Pathol 1999 ; 155: 1549–55.
26. 26 Pujuguet P, Del Maestro L, Gautreau A, Louvard D, Arpin M. Ezrin regulates E‐cadherin‐dependent adherens junction assembly through Rac1 activation. Mol Biol Cell 2003 ; 14: 2181–91.
27. 27 Choi SH, Takahashi K, Eto H, Yoon SS, Tanabe KK. CD44s expression in human colon carcinomas infuences growth of liver metastases. Int J Cancer 2000 ; 85: 523–6.
28. 28 Pereira PA, Rubenthiran U, Kaneko M, Jothy S, Smith AJ. CD44s expression mitigates the phenotype of human colorectal cancer hepatic metastases. Anticancer Res 2001 ; 21: 2713–7.
29. 29 Diaz LK, Zhou X, Wright ET, Cristofanilli M, Smith T, Yang Y, et al. CD44 expression is associated with increased survival in node‐negative invasive breast carcinoma. Clin Cancer Res 2005 ; 11: 3309–14.
30. 30 Lafeur EA, Koshkina N V, Stewart J, Jia SF, Worth LL, Duan X, et al. Increased fas expression reduces the metastatic potential of human osteosarcoma cells. Clin Cancer Res 2004 ; 10: 8114–19.